138 related articles for article (PubMed ID: 1831845)
21. Relationship of the subgingival microbiota to a chairside test for aspartate aminotransferase in gingival crevicular fluid.
Wong MY; Lu CL; Liu CM; Hou LT; Chang WK
J Periodontol; 1999 Jan; 70(1):57-62. PubMed ID: 10052771
[TBL] [Abstract][Full Text] [Related]
22. Relationship between crevicular aspartate aminotransferase levels and periodontal disease progression.
Oringer RJ; Howell TH; Nevins ML; Reasner DS; Davis GH; Sekler J; Fiorellini JP
J Periodontol; 2001 Jan; 72(1):17-24. PubMed ID: 11210069
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of components of gingival crevicular fluid as diagnostic tests.
Lamster IB
Ann Periodontol; 1997 Mar; 2(1):123-37. PubMed ID: 9151549
[TBL] [Abstract][Full Text] [Related]
24. Relationship between levels of aspartate aminotransferase in gingival crevicular fluid and gingival inflammation.
Persson GR; DeRouen TA; Page RC
J Periodontal Res; 1990 Jan; 25(1):17-24. PubMed ID: 2137168
[TBL] [Abstract][Full Text] [Related]
25. The relation of microbiologic data to aspartate aminotransferase enzyme activity in gingival crevicular fluid.
Kuru B; Noyan U; Yilmaz S; Kadir T; Acar O; Büget E
J Marmara Univ Dent Fac; 1996 Sep; 2(2-3):491-9. PubMed ID: 9569804
[TBL] [Abstract][Full Text] [Related]
26. The future of periodontal diagnostic testing.
Grbic JT; Engebretson SP
Dent Today; 2003 May; 22(5):103-11; quiz 111. PubMed ID: 12778680
[No Abstract] [Full Text] [Related]
27. Beta-glucuronidase activity in saliva: relationship to clinical periodontal parameters.
Lamster IB; Kaufman E; Grbic JT; Winston LJ; Singer RE
J Periodontol; 2003 Mar; 74(3):353-9. PubMed ID: 12710755
[TBL] [Abstract][Full Text] [Related]
28. [Measurement of sulcus fluid as a diagnostic measure in periodontal diseases. (I). Presence, composition and measurement methods of sulcus fluid].
Topoll H; Lange DE
Quintessenz; 1980 May; 31(5):89-93. PubMed ID: 7043539
[No Abstract] [Full Text] [Related]
29. Gingival fluid levels of acid and alkaline phosphatase.
Binder TA; Goodson JM; Socransky SS
J Periodontal Res; 1987 Jan; 22(1):14-9. PubMed ID: 2950223
[No Abstract] [Full Text] [Related]
30. Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test.
Mäntylä P; Stenman M; Kinane D; Salo T; Suomalainen K; Tikanoja S; Sorsa T
J Periodontal Res; 2006 Dec; 41(6):503-12. PubMed ID: 17076774
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of immunoassay-based MMP-8 detection in gingival crevicular fluid on a point-of-care platform.
Munjal SK; Prescher N; Struck F; Sorsa T; Maier K; Netuschil L
Ann N Y Acad Sci; 2007 Mar; 1098():490-2. PubMed ID: 17435156
[TBL] [Abstract][Full Text] [Related]
32. Assessment of periodontal disease activity by gingival crevicular fluid assay.
Smith QT
Northwest Dent; 1984; 63(3):29-32. PubMed ID: 6393052
[No Abstract] [Full Text] [Related]
33. Metronidazole as an adjunct to periodontal therapy with sub-gingival curettage.
Sterry KA; Langeroudi M; Dolby AE
Br Dent J; 1985 Mar; 158(5):176-8. PubMed ID: 3885976
[No Abstract] [Full Text] [Related]
34. Diagnostic tests for periodontal diseases.
Armitage GC
Curr Opin Dent; 1992 Mar; 2():53-62. PubMed ID: 1520939
[TBL] [Abstract][Full Text] [Related]
35. Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases.
Sorsa T; Gursoy UK; Nwhator S; Hernandez M; Tervahartiala T; Leppilahti J; Gursoy M; Könönen E; Emingil G; Pussinen PJ; Mäntylä P
Periodontol 2000; 2016 Feb; 70(1):142-63. PubMed ID: 26662488
[TBL] [Abstract][Full Text] [Related]
36. Advances in periodontal diagnosis. 8. Commercial diagnostic kits based on GCF proteolytic and hydrolytic enzyme levels.
Eley BM; Cox SW
Br Dent J; 1998 Apr; 184(8):373-6. PubMed ID: 9604504
[TBL] [Abstract][Full Text] [Related]
37. [Crevicular fluid: active site marker].
Margiotta V; Campofiorito G
Stomatol Mediterr; 1990; 10(2):83-104. PubMed ID: 2171149
[TBL] [Abstract][Full Text] [Related]
38. Treating periodontal diseases by blocking tissue-destructive enzymes.
Golub LM; Wolff M; Roberts S; Lee HM; Leung M; Payonk GS
J Am Dent Assoc; 1994 Feb; 125(2):163-9; discussion 169-71. PubMed ID: 8113524
[TBL] [Abstract][Full Text] [Related]
39. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss.
Offenbacher S; Odle BM; Van Dyke TE
J Periodontal Res; 1986 Mar; 21(2):101-12. PubMed ID: 2937899
[No Abstract] [Full Text] [Related]
40. Aspartate aminotransferase levels in gingival crevicular fluid before and after initial periodontal treatment.
Tsalikis L; Malaka E; Pavlitou E; Konstantinidis A
J Int Acad Periodontol; 2001 Jul; 3(3):68-74. PubMed ID: 12666944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
